Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents
NCT ID: NCT03864263
Last Updated: 2019-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2019-07-04
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The mother-to-child transmission route of hepatitis B virus is recognized as one of the most important routes of transmission, and recent studies have found that fathers who are carriers of HBV may also be one of the risk factors for HBV infection in children, but as far as the investigators know. Therefore, as a high-population area in China, the purpose of this study is to investigate the prevalence of HBV infection in this population.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hepatitis B Virus Infection After Liver Transplantation in Children
NCT03865966
Efficacy of Hepatitis B Vaccine Boosters Among Neonatally Vaccinated Children in Chongqing
NCT03867643
Evaluation of Immunoprotection Provided by Hepatitis B Vaccine After Birth in Healthy Children
NCT04439435
Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission
NCT03977987
Clinical Study on the Effect of IVF-ET on Mother-to-child Transmission of Hepatitis B Virus
NCT03932851
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The mother-to-child transmission route of hepatitis B virus is recognized as one of the most important routes of transmission, and recent studies have found that fathers who are carriers of HBV may also be one of the risk factors for HBV infection in children, but as far as the investigators know, only Studies in Taiwan and other places have reported studies on HBV infection in children with HBV-infected mothers, and no research has focused on the effects of fathers' HBV positivity on children. Therefore, as a high-population area in China, the purpose of this study is to investigate the prevalence of HBV infection in this population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children with HBsAg-positive patients
Children from a father or mother who are infected with HBV
Children without a family history of HBV
Children without a family history of HBV infection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children is vaccinated with hepatitis B vaccine after birth;
Exclusion Criteria
* Participants agreed to undergo clinical follow-up studies.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qiu Li
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Qiu Li
Children's Hospital of Chongqing Medical University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yao Zhao
Role: PRINCIPAL_INVESTIGATOR
Chongqing Children's Hospital of Chongqing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chongqing Children's Hospital of Chongqing Medical University
Chongqing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yao Zhao
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-30
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.